Intravenously Administered, Retinoid Activating Nanoparticles Increase Lifespan and Reduce Neurodegeneration in the SOD1
Dysregulation of the retinoic acid (RA) signaling pathway is observed in amyotrophic lateral sclerosis (ALS) and other neurodegenerative disorders. Here, we investigated the therapeutic potential of retinoid activation via the RA receptor β (RARβ) in the SOD1
Front Bioeng Biotechnol
Digital Object Identifier (DOI)
Medina, David X.; Chung, Eugene P; Teague, Collin D; Bowser, Robert; and Sirianni, Rachael W, "Intravenously Administered, Retinoid Activating Nanoparticles Increase Lifespan and Reduce Neurodegeneration in the SOD1" (2020). Translational Neuroscience. 473.